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Most people infected with Human T-cell Lymphotropic
Virus Type 1 (HTLV-1) remain clinically asymptomatic;
however, a minority develops the debilitating myelopa-
thy HAM/TSP. Current treatment of HAM/TSP is lim-
ited by our partial understanding of the protective
immune response to HTLV-1 and the pathogenesis of
HAM/TSP.
We wished to test the hypothesis that a gene expres-
sion signature in peripheral blood distinguishes between
patients with HAM/TSP and ACs. We investigated gen-
ome-wide transcription patterns in whole blood from
HTLV-1 asymptomatic carriers (AC; n=37), patients
with HAM/TSP (n=20) and uninfected control subjects
(n=17). We identified a 542-gene signature that was
deregulated in all HTLV-1+ individuals and predomi-
nantly comprised transcripts involved in p53-mediated
DNA damage responses (p=0.00489). An 80-gene signa-
ture distinguished patients with HAM/TSP from those
with the clinically similar disease multiple sclerosis.
Paradoxically, at a given proviral load patients with
HAM/TSP, but not ACs, over-expressed antiviral inter-
feron-stimulated genes (ISGs; p=0.00859).
Expression of these ISGs (assessed by quantitative
PCR and flow cytometry) was not limited to HTLV-1-
infected CD4+ T cells, suggesting that all peripheral
blood immune cells were exposed to interferons (IFN)
in vivo. Neither elevated IFN plasma levels nor an
abnormal capacity for IFN production was detected in
patients with HAM/TSP. However, peripheral immune
cells in patients with HAM/TSP were more sensitive to
IFN-alpha and IFN-gamma stimulation.
These findings suggest that chronic over-expression of
a specific subset of ISGs is ineffective in containing
HTLV-1 and may instead contribute to the pathogenesis
of HTLV-1-associated myelopathy.
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